Announcement PDF 9 November 2020 Sean Maloney Adviser, Listings Compliance (Perth) Level 40 Central Park 152 - 158 St George’s Terrace PERTH WA 6000 By email: tradinghaltsperth@asx.com.au Dear Sean Recce Pharmaceuticals Ltd (ASX:RCE) – Voluntary Suspension request Pursuant to ASX Listing Rule 17.2, Recce Pharmaceuticals Ltd ACN 124 849 065 (Company) requests for its securities to be voluntarily suspended pending the release of an announcement relating to anti-viral testing results. The Company requests that the voluntary suspension to remain in place until the earlier of the commencement of normal trading on Tuesday, 10 November 2020 or the release of an announcement by the Company in relation to the results. The Company is not aware of any reason why the voluntary suspension should not be granted. For any questions, please contact the undersigned on +61 2 8072 1400. Yours faithfully Alistair McKeough Company Secretary